Sumsuzzman D M, Wang Z, Langley JM, Moghadas SM, Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: A systematic review and meta-analysis, The Lancet Child & Adolescent Health 2025, 9: 393-403.
Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP, Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults, Nature Medicine 2025, 31(2): 647-652.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States. Clinical Infectious Diseases. 2024, 78(5): 1328-1335.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Moghadas SM, Bowman CS, Arino J, Competitive interference between influenza viral strains, Canadian Applied Mathematics Quarterly 2009, 17: 309–316.
Alexander ME, Dietrich SM, Hua Y, Moghadas SM, A comparative evaluation of modelling strategies for the effect of treatment and host interactions on the spread of drug resistance, Journal of Theoretical Biology 2009, 259: 253–263.
Moghadas SM, Prophylaxis of healthcare workers in an influenza pandemic, Handbook of Disease Burdens and Quality of Life Measures, Springer–Verlag, 2009, pp. 1419–1431.
Moghadas SM, Pizzi NJ, Wu J, Yan P, Managing public health crises: the role of models in pandemic preparedness, Influenza and Other Respiratory Viruses 2009, 3: 75–79.
Moghadas SM, Management of drug–resistance in the population: influenza as a case study, Proceedings of the Royal Society of London B 2008, 275: 1163–1169.
Moghadas SM, Bowman CS, Röst G, Wu J, Population–wide emergence of antiviral resistance during pandemic influenza, PLoS One 2008, 3(3): e1839.
Alexander ME, Moghadas SM, Röst G, Wu J, A delay differential model for pandemic influenza with antiviral treatment, Bulletin of Mathematical Biology 2008, 70: 382–397.
Moghadas SM, Corbett BD, Limit cycles in a generalized Gause–type predator–prey model, Chaos, Solitons & Fractals 2008, 37: 1343–1355.
Moghadas SM, Alexander ME, Sahai BM, Waning herd immunity: a challenge for eradication of measles, Rocky Mountain Journal of Mathematics 2008, 38: 1587–1607.
Alexander ME, Bowman CS, Feng Z, Gardam M, Moghadas SM, Röst G, Wu J, Yan P, Emergence of drug–resistance: implications for antiviral control of pandemic influenza, Proceedings of the Royal Society of London B 2007, 274: 1675–1684.